News & Articles

The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity

Corning expands cell culture portfolio with 3D liver models that better recapitulate in vivo behavior and deliver a more physiologically relevant model for improved drug safety and efficacy screening

Innovation and growth remain a priority to support customers and COVID-19 initiatives

The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction

Scientific, technological and communications excellence has been celebrated at the Virtual Cancer and Immunology Research Summit, with Logos Biosystems, INTEGRA Biosciences and Sartorius among those recognized

In this guest editorial, explore how artificial intelligence is becoming a powerful tool for drug discovery

First rapid antigen test with performance data on children

Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications

VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

Watch this on-demand webinar for expert insight into spectral cell analysis and how it may be used to generate parametric data

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

Linda Lee, senior research scientist at C4 Therapeutics, describes how lab equipment reviews help to accelerate scientific progress

Discover the automated, quantitative, and label-free software-hardware integration set to accelerate therapeutics research

Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions

Panel designed to provide surveillance of ongoing mutations of virus that causes COVID-19

How blood culture diagnostics are enabling accurate pathogen identification, resistance detection, and timely therapy

IL-6 assay aids in care management by determining patients at risk for intubation with mechanical ventilation

Avacta’s AffiDX SARS-CoV-2 lateral flow test detects both B117 ‘Kent’ and D614G variants of the virus

The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab